Buprenorphine

AAAP is one of five organizations designated by the U.S. Department of Health and Human Services (DHHS) to provide such training for physicians to dispense buprenorphine in office practice for treatment of opioid dependence. AAAP Buprenorphine Training sessions meet the eight (8) hour course requirement for obtaining Continuing Medical Education (CME) accreditation and qualify physicians for reviewal to prescribe.

 

For users who have previously registered to take the web-based course.


Buprenorphine and Office-Based Treatment of Opioid Dependence

Training Options

The web-based Training, found here or at http://training.aaap.org, will guide you through study material, modules, and the post tests to complete your training and receive your Certificate of Completion and CME Certificate. To receive your CME credits, you MUST pay for the entire course.  AAAP buprenorphine training sessions meet the requirements specified in the Drug Addiction Treatment Act of 2000.

Online Training Course Fees: 

AAAP Member: $99.00

Non-Members: $171.00  

How to Prepare for a DEA Visit                

If you are providing office-based treatment of opioid dependence, you should know that DATA 2000 requires the Drug Enforcement Agency to inspect physicians' office-based practices. The DEA has spent time in recent months preparing to inspect a greater number of these office-based settings, and several AAAP Board members recently had the opportunity to speak with DEA staff about the purpose of these visits and procedures to be used. Click here for information on those discussions and assistance in preparing for a DEA visit.

Please Note: As of October 1st AAAP will no longer support the use of CD-Rom Training of Buprenorphine and Office-Based Treatment of Opioid Dependence